Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.
2.

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Caldwell RG, Wilson JB, Anderson SJ, Longnecker R.

Immunity. 1998 Sep;9(3):405-11.

3.

Activation of the Rap GTPases in B lymphocytes modulates B cell antigen receptor-induced activation of Akt but has no effect on MAPK activation.

Christian SL, Lee RL, McLeod SJ, Burgess AE, Li AH, Dang-Lawson M, Lin KB, Gold MR.

J Biol Chem. 2003 Oct 24;278(43):41756-67. Epub 2003 Aug 6.

4.

The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.

Portis T, Cooper L, Dennis P, Longnecker R.

Front Biosci. 2002 Feb 1;7:d414-26. Review.

PMID:
11815296
5.

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Khwaja A, Rodriguez-Viciana P, Wennström S, Warne PH, Downward J.

EMBO J. 1997 May 15;16(10):2783-93.

6.
7.
8.

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.

Longo PG, Laurenti L, Gobessi S, Sica S, Leone G, Efremov DG.

Blood. 2008 Jan 15;111(2):846-55. Epub 2007 Oct 10.

9.

The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.

Ingham RJ, Raaijmakers J, Lim CS, Mbamalu G, Gish G, Chen F, Matskova L, Ernberg I, Winberg G, Pawson T.

J Biol Chem. 2005 Oct 7;280(40):34133-42. Epub 2005 Aug 8.

10.

The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.

Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, Longnecker R, Dykstra ML, Pierce SK.

Int Rev Immunol. 2001;20(6):805-35. Review.

PMID:
11913951
11.
12.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
13.
15.
16.

Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival.

Gingery A, Bradley E, Shaw A, Oursler MJ.

J Cell Biochem. 2003 May 1;89(1):165-79.

PMID:
12682917
17.

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Pang MF, Lin KW, Peh SC.

Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Review.

PMID:
19082921
18.

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

Guasparri I, Bubman D, Cesarman E.

Blood. 2008 Apr 1;111(7):3813-20. doi: 10.1182/blood-2007-03-080309. Epub 2008 Jan 29. Erratum in: Blood. 2008 Jul 15;112(2):452.

19.

Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.

Hoover RR, Gerlach MJ, Koh EY, Daley GQ.

Oncogene. 2001 Sep 13;20(41):5826-35.

20.

Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.

Newbern J, Taylor A, Robinson M, Li L, Milligan CE.

J Neurochem. 2005 Sep;94(6):1652-65. Epub 2005 Jul 25.

Supplemental Content

Support Center